Dr. Zafar Latif, MD

Dr. Latif practices at Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District.

Dr. Latif's NPI, 1861627663, was assigned on May 21, 2009. Dr. Latif graduated from Aga Khan Medical College in 2004. Dr. Latif holds Florida license 113492.

Dr. Latif's primary practice is Halifax Health Medical Center of Daytona Beach, at 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 in Volusia County. The practice phone is (386) 254-4000.

Dr. Latif's primary practice is Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District. Dr. Latif is also affiliated with AdventHealth Daytona Beach. The medical group on file is Halifax Health. Dmand AI also links Dr. Latif to 3 more hospitals and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Latif practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Latif's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Latif is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Latif's licenses on file in 3 states: Florida, Tennessee and Arkansas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Latif treats.

CMS data shows 857 Medicare services from Dr. Latif across 8 procedure codes in 2024, for 306 Medicare patients. Medicare paid $57,945 for them.

CMS counts 306 Medicare patients who saw Dr. Latif in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Latif's median patient age at 73, with 54% women.

In 2024, Dr. Latif wrote 2,017 Medicare Part D claims for 302 patients. 76% of them were for generic drugs. CMS names the drug for 1,612 of them, across 55 drugs with 11 or more claims each, at $2,621,301 in total drug cost. In 2023, CMS named 1,683 claims across 52 drugs.

Dr. Latif accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Latif as offering telehealth.

Dmand AI links 31 papers to Dr. Latif, published from 2011 to 2019. 2013 was the busiest year, with 5. The most frequent topics are Diabetes Mellitus, Type 2, Glycated Hemoglobin and Hypoglycemic Agents. Dr. Latif has published most often in Indian J Endocrinol Metab. Dr. Latif's most frequent co-authors are Sanjay Kalra, MD, Amit Jain, MD and Csaba Pal Kovesdy, MD.

Dmand AI links Dr. Latif to 1 clinical trial.

CMS Open Payments shows 58 general payments to Dr. Latif from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Novartis Pharmaceuticals Corporation paid the most, $402.

Dmand AI lists 1 award for Dr. Latif, most recently CMS Stage 1 EHR in 2013.

Dr. Latif graduated from Aga Khan Medical College in 2004.

Dr. Latif is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.